Differential Healing Activities of CD34 + and CD14 + Endothelial Cell Progenitors
- 1 April 2006
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 26 (4), 758-764
- https://doi.org/10.1161/01.atv.0000203513.29227.6f
Abstract
Objective— Peripheral blood contains primitive (stem cell-like) and monocytic-like endothelial cell progenitors. Diabetes apparently converts these primitive progenitors, from a pro-angiogenic to anti-angiogenic phenotype. Monocytic progenitors seem to be less affected by diabetes, but potential pro-angiogenic activities of freshly isolated monocytic progenitors remain unexplored. We compared the ability of primitive and monocytic endothelial cell progenitors to stimulate vascular growth and healing in diabetes and investigated potential molecular mechanisms through which the cells mediate their in vivo effects. Methods and Results— Human CD34 + primitive progenitors and CD14 + monocytic progenitors were injected locally into the ischemic limbs of diabetic mice. CD14 + cell therapy improved healing and vessel growth, although not as rapidly or effectively as CD34 + cell treatment. Western blot analysis revealed that cell therapy modulated expression of molecules in the VEGF, MCP-1, and angiopoietin pathways. Conclusions— Injection of freshly isolated circulating CD14 + cells improves healing and vascular growth indicating their potential for use in acute clinical settings. Importantly, CD14 + cells could provide a therapeutic option for people with diabetes, the function of whose CD34 + cells may be compromised. At least some progenitor-induced healing probably is mediated through increased sensitivity to VEGF and increases in MCP-1, and possibly modulation of angiopoietins.Keywords
This publication has 28 references indexed in Scilit:
- Obese Diabetic Mouse Environment Differentially Affects Primitive and Monocytic Endothelial Cell ProgenitorsThe International Journal of Cell Cloning, 2005
- Mechanical, cellular, and molecular factors interact to modulate circulating endothelial cell progenitorsAmerican Journal of Physiology-Heart and Circulatory Physiology, 2004
- DITPA stimulates arteriolar growth and modifies myocardial postinfarction remodelingAmerican Journal of Physiology-Heart and Circulatory Physiology, 2004
- Relevance of Monocytic Features for Neovascularization Capacity of Circulating Endothelial Progenitor CellsCirculation, 2003
- Transdifferentiation of Human Peripheral Blood CD34 + -Enriched Cell Population Into Cardiomyocytes, Endothelial Cells, and Smooth Muscle Cells In VivoCirculation, 2003
- LeprdbDiabetic Mouse Bone Marrow Cells Inhibit Skin Wound Vascularization but Promote Wound HealingCirculation Research, 2003
- In vivo administration of vascular endothelial growth factor (VEGF) and its antagonist, soluble neuropilin-1, predicts a role of VEGF in the progression of acute myeloid leukemia in vivoBlood, 2002
- Blood-derived angioblasts accelerate blood-flow restoration in diabetic miceJCI Insight, 2000
- Transplanted cord blood–derived endothelial precursor cells augment postnatal neovascularizationJCI Insight, 2000
- Monocyte activation in angiogenesis and collateral growth in the rabbit hindlimb.JCI Insight, 1998